Improved right ventricular function following transapical transcatheter mitral valve implantation for severe mitral regurgitation

BACKGROUND: Transapical transcatheter mitral valve implantation (TMVI) may be a therapeutic option for patients with severe mitral regurgitation (MR) excluded from cardiac surgery due to excessive risk. Exclusion criteria frequently include pulmonary hypertension and right ventricular (RV) dysfuncti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hungerford, Sara, Bart, Nicole, Jansz, Paul, Kay, Sharon, Emmanuel, Sam, Namasivayam, Mayooran, Dahle, Gry, Duncan, Alison, Hayward, Christopher, Muller, David W.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749427/
https://www.ncbi.nlm.nih.gov/pubmed/33365382
http://dx.doi.org/10.1016/j.ijcha.2020.100687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749427/
https://www.ncbi.nlm.nih.gov/pubmed/33365382
http://dx.doi.org/10.1016/j.ijcha.2020.100687

Ejemplares similares